These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 720037)

  • 1. Treatment with mesoridazine and thioridazine in chronic schizophrenia: II. Potential predictors of drug response.
    Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
    Compr Psychiatry; 1978; 19(6):527-32. PubMed ID: 720037
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with mesoridazine and thioridazine in chronic schizophrenia: I. Assessment of clinical and electrophysiologic responses in refractory hallucinating schizophrenics.
    Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
    Compr Psychiatry; 1978; 19(6):517-25. PubMed ID: 720036
    [No Abstract]   [Full Text] [Related]  

  • 3. A CNV typology of chronic schizophrenics and response to drug treatment.
    Tecce JJ; Gardos G; Cole JO; Bowers PA
    Psychopharmacol Bull; 1979 Jan; 15(1):39-41. PubMed ID: 419248
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a possible new metabolite of thioridazine and mesoridazine from human plasma.
    Dinovo EC; Gottschalk LA; Noble EP; Biener R
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):489-96. PubMed ID: 4824823
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
    Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac conduction and rhythm disturbances following suicidal ingestion of mesoridazine.
    Niemann JT; Stapczynski JS; Rothstein RJ; Laks MM
    Ann Emerg Med; 1981 Nov; 10(11):585-8. PubMed ID: 7316263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy of thought disorder in chronic paranoid schizophrenia: a longitudinal study.
    Wilson IC; Paulson GW; Sandifer MG
    Dis Nerv Syst; 1968 Aug; 29(8):550-1. PubMed ID: 4877898
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients.
    Carrillo JA; Ramos SI; Herraiz AG; Llerena A; Agundez JA; Berecz R; Duran M; Benítez J
    J Clin Psychopharmacol; 1999 Dec; 19(6):494-9. PubMed ID: 10587283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mesoridazine (TPS 23 Sandoz) in acute psychotic states].
    Jost F; Zmorski T
    Schweiz Arch Neurol Neurochir Psychiatr; 1973; 112(1):131-42. PubMed ID: 4570413
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of response to neuroleptic treatment: factors influencing the amelioration of individual symptoms in psychotic patients.
    Axelsson R; Ohman R
    Acta Psychiatr Scand; 1987 Dec; 76(6):707-14. PubMed ID: 3442262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of thioridazine and its side-chain derivative, mesoridazine, in chronic male hospitalized psychiatric patients.
    Mena A; Grayson H; Cohen S
    J New Drugs; 1966; 6(6):345-8. PubMed ID: 5341416
    [No Abstract]   [Full Text] [Related]  

  • 13. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
    Shvartsburd A; Nwokeafor V; Smith RC
    Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between plasma thioridazine level and the symptoms of paranoid schizophrenia].
    Afeltowicz Z
    Psychiatr Pol; 1979; 13(3):223-33. PubMed ID: 472063
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic evaluation of mesoridazine (Serentil).
    Dillenkoffer RL; Gallant DM; Phillips JH
    Curr Ther Res Clin Exp; 1972 Feb; 14(2):71-2. PubMed ID: 4622440
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of P-5227 and thioridazine in chronic schizophrenic patients.
    J Clin Pharmacol J New Drugs; 1967; 7(5):287-95. PubMed ID: 5237376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychopharmacological mass screening using Inofal].
    Eckmann F; Immich H; Newmann H; Schäpperle O; Schwarz H
    Int Pharmacopsychiatry; 1971; 6(1):23-7. PubMed ID: 5163165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.